Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Neurocrine Bioscience buy Morgan Stanley

Start price
€112.45
31.07.25 / 50%
Target price
€138.22
31.07.26
Performance (%)
-0.89%
Price
€111.45
01.08.25
Summary
This prediction is currently active. Since the start of the prediction for Neurocrine Bioscience the price has only changed by -0.89%. This prediction currently runs until 31.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w
Neurocrine Bioscience -0.89%
iShares Core DAX® -3.352%
iShares Nasdaq 100 -0.740%
iShares Nikkei 225® -1.885%
iShares S&P 500 -0.952%

Comments by Morgan_Stanley for this prediction

In the thread Neurocrine Bioscience diskutieren
Prediction Buy
Perf. (%) -0.89%
Target price 138.218
Change
Ends at 31.07.26

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Morgan Stanley from $150.00 to $158.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat

Stopped prediction by Morgan_Stanley for Neurocrine Bioscience

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€112.50
22.07.25
€128.31
22.07.26
-1.11%
01.08.25

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€105.00
07.03.25
€138.30
07.03.26
6.14%
01.08.25

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€148.00
04.02.25
€178.90
04.02.26
-24.70%
01.08.25

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€136.55
12.07.24
€155.89
12.07.25
-17.17%
13.07.25

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€124.65
12.06.24
€147.54
12.06.25
-14.64%
13.06.25